Abstract
Over the past few decades, several cardiac autoantibodies have been reported in sera from patients with dilated cardiomyopathy (DCM). Immunoadsorption (IA) therapy is one of the therapeutic tools to remove such autoantibodies. The objective of this study was to investigate functional effects of IA therapy using a tryptophan column in severe DCM patients. Of 49 patients enrolled, 44 were randomized from 10 sites in Japan. IA therapy was conducted in 40 patients with DCM (refractory to standard therapy for heart failure, New York Heart Association [NYHA] class III/IV, left ventricular ejection fraction [LVEF] <30%). Mean echocardiographic LVEF was significantly improved (23.8 ± 1.3% to 25.9 ± 1.3%, P = 0.0015). However, mean radionuclide LVEF over 3 months of IA therapy was not significantly improved (20.8 ± 1.1% to 21.9 ± 1%, P = 0.0605). The cardiothoracic ratio was also significantly decreased (P = 0.0010). NYHA functional class (P < 0.0001), subjective symptoms assessed by a quality of life questionnaire (P = 0.0022), maximum oxygen consumption (P = 0.0074), and 6-minute walk distance (P = 0.0050) were improved after IA therapy. Subgroup analysis revealed improvement of echocardiographic LVEF in patients with higher baseline ...Continue Reading
References
Mar 11, 1991·Circulation·D M ManciniJ R Wilson
Jan 1, 1989·Circulation Research·C J LimasC Limas
Aug 1, 1995·Clinical and Experimental Immunology·A H MulderC G Kallenberg
May 5, 1999·Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis·Y TsuboiT Yamada
Jan 15, 2000·Journal of the American College of Cardiology·B LauerH P Schultheiss
Feb 2, 2000·Circulation·J MüllerR Hetzer
Feb 24, 2001·Journal of the American College of Cardiology·M IwataS Ogawa
Apr 3, 2001·Circulation Research·M IwataS Ogawa
Oct 23, 2001·Japanese Circulation Journal·A BabaUNKNOWN Keio Interhospital Cardiology Study (KICS) Group
Jun 21, 2002·American Heart Journal·Rahat S WarraichIlkay Kasac
Oct 2, 2002·Journal of the American College of Cardiology·Akiyasu BabaSatoshi Ogawa
Nov 6, 2002·Circulation·Alexander StaudtStephan B Felix
Jun 7, 2003·Journal of Autoimmunity·Reza MobiniMichael Fu
Jun 17, 2003·Journal of Cardiovascular Pharmacology and Therapeutics·Gerian C Grönefeld, Stefan H Hohnloser
Nov 5, 2003·Nature Medicine·Taku OkazakiTasuku Honjo
Mar 19, 2004·Journal of the American College of Cardiology·Yukiko FukudaSatoshi Ogawa
Jul 3, 2004·European Heart Journal·Akiyasu BabaMichael Fu
Dec 8, 2004·Blood Purification·Shigeto OdaMasamune Sakai
Oct 8, 2005·American Heart Journal·Alexander StaudtStephan B Felix
Aug 28, 2007·American Heart Journal·Pascal de GrooteChristophe Bauters
May 27, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Akiyasu BabaTsutomu Yoshikawa
Feb 10, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·UNKNOWN JCS Joint Working Group
Feb 12, 2011·Journal of Clinical Apheresis·Yuji NagatomoTsutomu Yoshikawa
Aug 16, 2012·European Journal of Heart Failure·Michael DandelRoland Hetzer
Oct 27, 2012·European Heart Journal·Sabine AmelingStephan B Felix
Oct 28, 2014·Journal of Clinical Apheresis·Markus ReinthalerStefan B Felix
Citations
Feb 7, 2017·Autoimmunity Reviews·Niels-Peter BeckerIngolf Schimke
Jun 11, 2019·Journal of Clinical Apheresis·Anand PadmanabhanGuest Editor Joseph Schwartz
Nov 17, 2019·Biomolecules·Karolina WeinmannMirjam Keßler
Jan 21, 2020·Circulation. Heart Failure·Hans-Dirk DüngenJaved Butler
Jan 31, 2020·Dimensions of Critical Care Nursing : DCCN·Oksana Narovlyanskaya, Elizabeth J Winokur
Jul 5, 2017·Chemical & Pharmaceutical Bulletin·Atsushi MaharaTetsuji Yamaoka
Mar 16, 2018·Current Treatment Options in Cardiovascular Medicine·Paulino Alvarez, Alexandros Briasoulis
May 12, 2016·Current Opinion in Rheumatology·Noel R Rose
Jul 1, 2021·Medicine·Ru-Tao BianWei-Yu Li